These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 7533120

  • 1. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C.
    Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, Bonkovsky HL.
    Hepatology; 1995 Mar; 21(3):613-9. PubMed ID: 7533120
    [Abstract] [Full Text] [Related]

  • 2. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y, Bayraktar M, Gurakar A, Hassanein TI, Van Thiel DH.
    Hepatogastroenterology; 1997 Mar; 44(14):417-25. PubMed ID: 9164512
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes.
    Todros L, Saracco G, Durazzo M, Abate ML, Touscoz G, Scaglione L, Verme G, Rizzetto M.
    Hepatology; 1995 Nov; 22(5):1374-8. PubMed ID: 7590650
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prevalence of GBV-C/HGV-RNA, virus genotypes, and anti-E2 antibodies in autoimmune hepatitis.
    Tribl B, Schöniger-Hekele M, Petermann D, Bakos S, Penner E, Müller C.
    Am J Gastroenterol; 1999 Nov; 94(11):3336-40. PubMed ID: 10566740
    [Abstract] [Full Text] [Related]

  • 6. [Heterogeneity of antimicrosomal autoantibodies in chronic hepatitis C virus infection and delta hepatitis].
    Durazzo M, Costa C, Schmidt E, Loges S, Scaglione L, Touscoz AG, Smedile A, Manns MP, Rizzetto M, Pagano G.
    Ann Ital Med Int; 1995 Nov; 10(2):93-7. PubMed ID: 7542466
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Prevalence of circulating autoantibodies in healthy individuals].
    Teubner A, Tillmann HL, Schuppan D, Gericke G, Manns MP, Stölzel U.
    Med Klin (Munich); 2002 Nov 15; 97(11):645-9. PubMed ID: 12434272
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy.
    Tran A, Quaranta JF, Benzaken S, Thiers V, Chau HT, Hastier P, Regnier D, Dreyfus G, Pradier C, Sadoul JL.
    Hepatology; 1993 Aug 15; 18(2):253-7. PubMed ID: 7687977
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of autoimmune and extra-hepatic manifestations of HCV infection.
    Lunel F, Cacoub P.
    Ann Med Interne (Paris); 2000 Feb 15; 151(1):58-64. PubMed ID: 10761564
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interferon and steroid treatment in patients with chronic hepatitis C and antinuclear or anti-liver-kidney microsomal antibodies.
    Provenzano G, Almasio P, Fabiano C, Magrin S, Pinzello G, Vaccaro A, Craxì A.
    Ital J Gastroenterol; 1996 Sep 15; 28(7):377-80. PubMed ID: 8937938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.